New Prospective Multicenter Long-Term Balloon Kyphoplasty Study To Be Featured On American Health Radio

Kyphon Inc. (Nasdaq: KYPH) announced today that Richard Mott, Kyphon's president and
chief executive officer, and Dr. Rudolph Buckley, orthopaedic spine surgeon
from Slocum Dickson Medical Group in Utica, New York, will be interviewed
on American Health Radio, the nationally-syndicated health radio program
hosted by Scott Broder. Dr. Buckley is co-author of the first-ever
prospective multicenter long-term clinical study evaluating the benefits of
balloon kyphoplasty treatment of osteoporotic spinal fractures. This study
was recently published in the September 1, 2006 issue of Spine, the leading
subspecialty, peer-reviewed journal reporting on spinal disorders.



The program will air live today, Monday, October 2, 2006 at 6:00 p.m.
Central Time and can be accessed at wrmn1410. A replay of
the program will be available on Wednesday, October 4 at 8:00 p.m. Central
Time and on Friday, October 6 at 6:00 p.m. Central Time at
healthradionetwork.



This latest study in the growing body of evidence for balloon
kyphoplasty showed that patients experienced rapid and sustained
improvement in back pain, back function and quality of life for two years
post-procedure. In addition, the study documented improvements in restoring
vertebral height and high patient satisfaction with the procedure. To view
a Multimedia News Release, which reveals details about the study, please
visit prnewswire/mnr/kyphon/25116.



Spinal Fractures and Balloon Kyphoplasty



The majority of spinal fractures are caused by osteoporosis, a
progressive disease that causes bones to become brittle, weak and
susceptible to painful, debilitating fractures. According to the National
Osteoporosis Foundation, one-in-two women and one-in-four men over the age
of 50 in the U.S. will experience a spinal fracture, with two-thirds going
undiagnosed. Cancer, including multiple myeloma and the metastasis of other
tumors to bone, can also affect bone quality and lead to spinal fracture.
In cases of multiple spinal fractures, a loss of height and stooped posture
-- known as kyphosis -- can occur, which affects the ability to stand
upright and walk, and can make simple tasks like lifting a bag of groceries
or getting dressed difficult. Left untreated, each additional fracture
increases future fracture risk, accelerating the effects of the spinal
deformity. Increasing kyphosis is associated with decreased respiratory
function, reduced ability to walk, decreased quality of life, and an
increased risk of early mortality.



Supplemental calcium with vitamin D and prescription medications are
often used to slow down bone loss and treat the underlying osteoporosis.
Medical management, however, does not always prevent fracture. Despite the
advances in drug therapy, spinal fractures continue to occur and may
require surgical intervention. First performed in 1998, balloon kyphoplasty
is a minimally invasive procedure which can treat the fracture, reduce
pain, restore quality of life, and repair some or all of the associated
deformity. To date, over 275,000 spinal fractures have been treated using
balloon kyphoplasty worldwide.



To request a full copy of the study, go to
kyphon/professionals/pcpnewsletterrequests.cfm.



To find a Spine Specialist who performs Balloon Kyphoplasty in your
area, go to kyphon/phys_Locator.cfm.



For additional downloadable media materials, go to
kyphon/media.cfm.



About Kyphon Inc



Kyphon develops and markets medical devices designed to restore spinal
function using minimally invasive technologies. The company's KyphX line of
products is used in balloon kyphoplasty, a minimally invasive procedure to
treat spinal fractures caused by osteoporosis or cancer. For more
information, visit Kyphon's Web site at kyphon.



Kyphon and KyphX are registered trademarks of Kyphon Inc


Kyphon Inc

kyphon